Health systems, patients factors, and quality of care for diabetes: A synthesis of findings from the TRIAD study

Diabetes Care

Volumn 33, Issue 4, 2010, Pages 940-947

  Selby, Joe V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COST CONTROL; COST OF ILLNESS; DIABETES MELLITUS; DIABETIC PATIENT; DOCTOR PATIENT RELATION; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HUMAN; MORTALITY; PSYCHOSOCIAL CARE; REIMBURSEMENT; REVIEW;

DELIVERY OF HEALTH CARE; DIABETES MELLITUS; HUMANS; MODELS, THEORETICAL; QUALITY OF HEALTH CARE;

EID: 77953036938     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-1802     Document Type: Review

References (60)

1. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 2006;29:2114-2116
2. Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 1997;20:1396-1402 (Pubitemid 27366814)
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-986
4. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-713
5. Pyǒrälä K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study. Diabetes Care 1997;20: 614-620 (Pubitemid 27143424)
6. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy: I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308: 81-106
7. Beckles GL, Engelgau MM, Narayan KM, Herman WH, Aubert RE, Williamson DF. Population-based assessment of the level of care among adults with diabetes in the U.S. Diabetes Care 1998;21:1432-1438
8. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 2002;136:565-574 (Pubitemid 34407040)
9. McClain MR, Wennberg DE, Sherwin RW, Steinmann WC, Rice JC. Trends in the diabetes quality improvement project measures in Maine from 1994 to 1999. Diabetes Care 2003;26:597-601
10. Epstein RS, Sherwood LM. From outcomes research to disease management: a guide for the perplexed. Ann Intern Med 1996;124:832-837 (Pubitemid 26128414)
11. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Millwood) 2001;20:64-78
12. Kerr EA, Mittman BS, Hays RD, Siu AL, Leake B, Brook RH. Managed care and capitation in California: how do physicians at financial risk control their own utilization? Ann Intern Med 1995;123:500-504
13. The TRIAD Study Group. The Translating Research Into Action for Diabetes (TRIAD) study: a multicenter study of diabetes in managed care. Diabetes Care 2002;25:386-389
14. Donabedian A. The definition of quality. In Explorations in Quality Assessment and Monitoring. Vol. 1. Ann Arbor, Michigan, Health Administration Press, 1985
15. Kerr EA, Gerzoff RB, Krein SL, Selby JV, Piette JD, Curb JD, Herman WH, Marrero DG, Narayan KM, Safford MM, Thompson T, Mangione CM. Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med 2004; 141:272-281
16. Kim C, Williamson DF, Mangione CM, Safford MM, Selby JV, Marrero DG, Curb JD, Thompson TJ, Narayan KM, Herman WH, Translating Research Into Action for Diabetes (TRIAD) Study. Managed care organization and the quality of diabetes care: the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2004;27:1529-1534
17. Mangione CM, Gerzoff RB, Williamson DF, Steers WN, Kerr EA, Brown AF, Waitzfelder BE, Marrero DG, Dudley RA, Kim C, Herman W, Thompson TJ, Safford MM, Selby JV, TRIAD Study Group. The association between quality of care and the intensity of diabetes disease management programs. Ann Intern Med 2006; 145:107-116 (Pubitemid 46780584)
18. Ackermann RT, Thompson TJ, Selby JV, Safford MM, Stevens M, Brown AF, Narayan KMV. Is the number of documented diabetes process-of-care indicators associated with cardiometabolic risk factor levels, patient satisfaction, or self-rated quality of diabetes care? The Translating Research into Action for Diabetes (TRIAD) Study. Diabetes Care 2006;29: 2108-2113
19. Ettner S, Thompson TJ, Stevens MR, Mangione CM, Kim C, Steers WN, Goewey J, Brown AF, Chung RS, Narayan KMV; the TRIAD Study Group. Are physician reimbursement strategies associated with processes of care and patient satisfaction for patients with diabetes in managed care? Health Services Res 2006; 41:1221-1241
20. Kim C, Steers WN, Herman WH, Mangione CM, Narayan KM, Ettner SL. Physician compensation from salary and quality of diabetes care. J Gen Intern Med 2007;22:448-452
21. Hillman AL, Pauly MV, Kerstein JJ. How do financial incentives affect physicians' clinical decisions and the financial performance of health maintenance organizations? N Engl J Med 1989;321:86-92
22. Conrad DA, Maynard C, Cheadle A, Ramsey S, Marcus-Smith M, Kirz H, Madden CA, Martin D, Perrin EB, Wickizer T, Zierler B, Ross A, Noren J, Liang SY. Primary care physician compensation method in medical groups: does it influence the use and cost of health services for enrollees in managed care organizations? JAMA 1998;279:853-858
23. Kim C, Williamson DF, Herman WH, Safford MM, Selby JV, Marrero DG, Curb JD, Thompson TJ, Narayan KM, Mangione CM, TRIAD Study Group. Referral management and the care of patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) study. Am J Manag Care 2004;10:137-143 (Pubitemid 38332388)
24. Karter AJ, Stevens MR, Herman WH, Ettner S, Marrero DG, Safford MM, Engelgau MM, Curb JD, Brown AF, Translating Research Into Action for Diabetes Study Group. Out-of-pocket costs and diabetes preventive services: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 2003;26:2294-2299
25. Tseng CW, Tierney EF, Gerzoff RB, Dudley RA, Waitzfelder B, Ackermann RT, Karter AJ, Piette J, Crosson JC, Ngo-Metzger Q, Chung R, Mangione CM. Race/ethnicity and economic differences in cost related medication underuse among insured adults with diabetes: The TRIAD study. Diabetes Care 2008; 31:261-266
26. Selby JV, Swain BE, Gerzoff RB, Karter AJ, Waitzfelder BE, Brown AF, Ackermann RT, Duru OK, Ferrara A, Herman W, Marrero DG, Caputo D, Narayan KM, TRIAD Study Group. Understanding the gap between good processes of diabetes care and poor intermediate outcomes: Translating Research Into Action for Diabetes (TRIAD). Med Care 2007;45:1144-1153
27. Schmittdiel JA, Ettner SL, Fung V, Huang J, Turk N, Quiter ES, Swain BE, Hsu JT, Mangione CM. Medicare Part D coverage gap and diabetes beneficiaries. Am J Manag Care 2009;15:189-193
28. Fung V, Mangione CM, Huang J, Turk N, Quiter E, Schmittdiel JA, Hsu J. Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage Prescription Drug Plan beneficiaries with diabetes. Health Serv Res. 30 December 2009 [Epub ahead of print]
29. Duru OK, Mangione CM, Hsu J, Steers WN, Quiter E, Turk N, Ettner SL, Schmittdiel JA, Tseng C-W. Responses to medication costs among diabetes patients in Medicare Part D: the Translating Research into Action for Diabetes (TRIAD) Study. J Am Geriatrics Society. In press
30. Schmittdiel JA, Uratsu CS, Karter AJ, Heisler M, Subramanian U, Mangione CM, Selby JV. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med 2008; 23:588-594
31. Schmittdiel JA, Uratsu CS, Fireman BH, Selby JV. The effectiveness of diabetes care management in managed care. Am J Manag Care 2009;15:295-301
32. Subramanian U, Ackermann RT, Brizendine EJ, Saha C, Rosenman MB, Willis DR, Marrero DG. Effect of advanced access scheduling on processes and intermediate outcomes of diabetes care and utilization. J Gen Intern Med 2009;24: 327-333
33. Duru OK, Schmittdiel JA, Dyer W, Parker M, Uratsu C, Chan J, Karter AJ. Mail-order pharmacy use and adherence to diabetes-related medications. Am J Manag Care 2010;16:33-40
34. McEwen LN, Hsiao VC, Nota-Kirby B, Kulpa G, Schmidt KG, Herman WH. Effect of a managed care disease management program on diabetes care. Am J Manag Care 2009;15:575-580
35. Kerr EA, Krein SL, Vijan S, Hofer TP, Hayward RA. Avoiding pitfalls in chronic disease quality measurement: a case for the next generation of technical quality measures. Am J Manag Care 2001;7:1033-1043 (Pubitemid 33080954)
36. Kerr EA, Smith DM, Hogan MM, Hofer TP, Krein SL, Bermann M, Hayward RA. Building a better quality measure: are some patients with 'poor quality' actually getting good care? Med Care 2003;41: 1173-1182
37. Selby JV, Uratsu CS, Fireman B, Schmittdiel JA, Peng T, Rodondi N, Karter AJ, Kerr EA. Treatment intensification and risk factor control: toward more clinically relevant quality measures. Med Care 2009;47:395-402
38. Duru OK, Gerzoff RB, Selby JV, Brown AF, Ackermann RT, Karter AJ, Ross S, Steers N, Herman WH, Waitzfelder B, Mangione CM. Identifying risk factors for racial disparities in diabetes outcomes: The Translating Research in Action for Diabetes (TRIAD) Study. Med Care 2009; 47:700-706
39. Gregg EW, Karter AJ, Gerzoff RB, Safford M, Brown A, Tseng C-W, Waitzfelder B, Herman W, Mangione C, Selby J, Thompson T, Dudley RA. Characteristics of insured patients with persistent gaps in diabetes care services: the Translating Research into Action for Diabetes (TRIAD) study. Med Care 2010;48:31-37
40. Subramanian U, Schmittdiel JA, Gavin N, Traylor A, Uratsu CS, Selby JV, Mangione CM. The association of patient age with cardiovascular disease risk factor treatment and control in diabetes. J Gen Intern Med 2009;24:1049-1052
41. Ferrara A, Williamson DF, Karter AJ, Thompson TJ, Kim C, Diabetes (TRIAD) Study Group. Sex differences in quality of health care related to ischemic heart disease prevention in patients with diabetes: The Translating Research Into Action for Diabetes (TRIAD) study, 2000-2001. Diabetes Care 2004;27:2974-2976
42. Ferrara A, Mangione CM, Kim C, Marrero DG, Curb D, Stevens M, Selby JV, Translating Research Into Action for Diabetes Study Group. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2008;31:69-74
43. Schmittdiel JA, Traylor A, Uratsu CS, Mangione CM, Subramanian U. The effect of physician gender, patient gender, and gender concordance on cardiovascular disease risk factor control and treatment in diabetes. J Womens Health (Larchmt) 2009;18:2065-2070
44. Brown AF, Gregg EW, Stevens MR, Karter AJ, Weinberger M, Safford MM, Gary TL, Caputo DA, Waitzfelder B, Kim C, Beckles GL. Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: The Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2005;28:2864-2870
45. Brown AF, Gerzoff RB, Karter AJ, Gregg E, Safford M, Waitzfelder B, Beckles GL, Brusuelas R, Mangione CM, TRIAD Study Group. Health behaviors and quality of care among Latinos with diabetes in managed care. Am J Public Health 2003;93: 1694-1698 (Pubitemid 38477637)
46. Gary TL, Safford MM, Gerzoff RB, Ettner SL, Karter AJ, Beckles GL, Brown AF. Perception of neighborhood problems, health behaviors, and diabetes outcomes among adults with diabetes in managed care: The Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2008;31:273-278
47. Karter AJ, Stevens MR, Gregg EW, Brown AF, Tseng CW, Marrero DG, Duru OK, Gary TL, Piette JD, Waitzfelder B, Herman WH, Beckles GL, Safford MM, Ettner SL. Educational disparities in rates of smoking among diabetic adults: The Translating Research Into Action for Diabetes Study. Am J Public Health 2008;98:365-370
48. Karter AJ, Stevens MR, Brown AF, Duru OK, Gregg EW, Gary TL, Beckles GL, Tseng CW, Marrero DG, Waitzfelder B, Herman WH, Piette JD, Safford MM, Ettner SL. Educational disparities in health behaviors among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study. BMC Public Health 2007;7:308
49. Duru OK, Gerzoff RB, Brown AF, Karter AJ, Kim C, Kountz D, Narayan KM, Schneider SH, Tseng CW, Waitzfelder B, Mangione CM. Predictors of sustained walking among diabetes patients in managed care: The Translating Research into Action for Diabetes (TRIAD) Study. J Gen Intern Med 2008;23:1194-1199
50. Ettner SL, Cadwell BL, Russell LB, Brown A, Karter AJ, Safford M, Mangione C, Beckles G, Herman WH, Thompson TJ, TRIAD Study Group. Investing time in health: do socioeconomically disadvantaged patients spend more or less extra time on diabetes self-care? Health Econ 2009;18:645-663
51. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16:606-613
52. Traylor AH, Subramanian U, Uratsu CS, Mangione CM, Selby JV, Schmitdiel JA. Patient race/ethnicity and patient-physician race/ethnicity concordance in the management of cardiovascular disease risk factors for patients with diabetes. Diabetes Care 2010;33:520-525
53. Kim C, McEwen LN, Kerr EA, Piette JD, Chames MC, Ferrara A, Herman WH. Preventive counseling among women with histories of gestational diabetes mellitus. Diabetes Care 2007;30:2489-2495 (Pubitemid 47547777)
54. Duru OK, Mangione CM, Steers NW, Herman WH, Karter AJ, Kountz D, Marrero DG, Safford MM, Waitzfelder B, Gerzoff RB, Huh S, Brown AF, TRIAD Study Group. The association between clinical care strategies and the attenuation of racial/ ethnic disparities in diabetes care: The Translating Research Into Action for Diabetes (TRIAD) Study. Med Care 2006; 44:1121-1128
55. Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk Van JT, Assendelft WJ. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care 2001;24:1821-1833
56. Landon BE, Hicks LS, O'Malley AJ, Lieu TA, Keegan T, McNeil BJ, Guadagnoli E. Improving the management of chronic disease at community health centers. N Engl J Med 2007;356:921-934
57. Hsu J, Price M, Huang J, Brand R, Fung V, Hui R, Fireman B, Newhouse JP, Selby JV. Unintended consequences of caps on Medicare drug benefits. N Engl J Med 2006;354:2349-2359
58. Spaulding A, Fendrick AM, Herman WH, Stevenson JG, Smith DG, Chernew ME, Parsons DM, Bruhnsen K, Rosen AB. A controlled trial of value-based insurance design: The MHealthy: Focus on Diabetes (FOD) trial. Implement Sci 2009;4:19
59. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-1589
60. Frohlich KL, Potvin L. The inequality paradox: the population approach and vulnerable populations. Am J Publ Hlth 2008;98:216-220